EFFECT OF SIDDHA NASAL DROPS( NASIROGA THYLA NASIYAM) IN THE MANAGEMENT OF SINUSITIS

SINGLE CENTRIC PHASE II OPEN CLINICAL TRIAL IN PEENISAM (SINUSITIS WITH THE INTERVENTION OF SIDDHA MEDICINE NASIROGA THYLA NASIYAM (NASAL DROPS) AMONG PATIENTS ATTENDING OPD AT AAGHIM ATTACHED WITH GSMC, CHENNAI. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103910

Enrollment

Registered

2026-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: NASIROGA THYLAM ( EXTERNAL): 4 DROPS ON EACH NOSTRIL,FOUR DAYS ONCE FOR 48 DAYS Control Intervention1: NOT APLLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: RHINNOREA PAIN AND TENDERNESS OVER PARANASAL SINUS RECCURENT SNEEZING ANOSMIA OR HYPOSMIA NASAL OBSTRUCTION

Exclusion criteria

Exclusion criteria: NASAL POLYP PREGNANT WOMEN AND LACTATING MOTHER ANY OTHER SYSTEMIC ILLNESS

Design outcomes

Primary

Measure	Time frame
THE OUTCOME WILL BE ASSESSED BY ADELAIDE DISEASE SEVERITY SCORETimepoint: THE OUTCOME WILL BE ASSESSED BY ADELAIDE DISEASE SEVERITY SCORE FOR 48 DAYS	—

Secondary

Measure	Time frame
THE OUTCOME WILL BE ASSESSED BY ADELAIDE DISEASE SEVERITY SCORETimepoint: 48 DAYS	—

Countries

India

Contacts

Public ContactM KANNAN

GOVERNMENT SIDDHA MEDICIAL COLLEGE, CHENNAI

vmkkannan2020@gmail.com8754312947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026